3B (i)], assessment of 4AD levels focusing on post-AI treatment showed a trend toward increased 4AD in patients who recurred when compared with patients who responded to AI therapy [ Fig. 3B (ii), t test P = 0.018, P adj . = 0.11].
Department of Defense 10.13039/100000005 PD220061 National Health and Medical Research Council 10.13039/501100000925 1195830 2008565 Group‐level comparisons showed a trend toward reduced functional connectivity between the left NBM and the VAN in PD‐VHs compared with PD‐NoVHs ( P = 0.018 uncorrected, Cohen's d = −0.661); however, this did not survive FDR correction ( P FDR = 0.060).
Current or previous smoking (p = .029) showed a trend for association with more frequent CCSVI diagnosis, while use of dietary supplements (p = .018) showed a trend for association with less frequent CCSVI diagnosis.
However, LSD post hoc comparisons showed a trend for mild deficits in SCA3 and SCA6 when compared to controls ( p = 0.018 and p = 0.041).
ALFF The ALFF of the left amygdala showed a trend interactive effect with group on the RT for anger ( F 3,60 = 3.58, p = 0.018), however, it did not survive the multiple comparison correction ( p FDR = 0.09).
The distribution profiles of neurite curvature of the control cases showed a trend depending on their age, resulting in an age-correlated decrease in the standard deviation of neurite curvature (Pearson’s r = -0.80, p = 0.018).
The DRSP/EE monotherapy group showed a trend towards reduced GDM risk (χ 2 = 5.552, P = 0.018), but this difference did not reach statistical significance after Bonferroni correction.
NP VDR mRNA Downregulation in LDD Patients Similar to blood VDR, the analysis of NP VDR expression also showed a trend toward lower levels in the LDD group compared to controls ( p = 0.018).
Compared to patients in Group 1, women over 65 showed a trend toward undertreatment across all risk categories, even if only in high-risk tumors did the difference reach statistical significance ( p = 0.018).
In the AD high-risk cohort, metabolite ratios in the AD meta region PCr/ATP, and Pi/ATP showed significant inverse associations with FDG uptake (P < 0.01), while PME/PDE showed a trend toward association (P = 0.018) (see Table 3 and Fig. 2 ).
The CDVAalso showed a trend of improvement at one month ( P = 0.018, Wilcoxon signed rank test) and three months postoperatively( P = 0.018, Wilcoxon signed rank test) when respectively compared to the preoperative value.
CA4 showed a trend towards right hemispheric asymmetry ( r RH = 0.490, r LH = 0.312, difference = 0.178, Z = 2.36, p = 0.018, FDR‐ p = 0.055).
During negative emotion regulation, the decreased left SMA activation in the NSSI group showed a trend-level correlation with higher DERS scores ( r = −0.44, P = 0.018), which did not survive the Bonferroni-corrected threshold of P < 0.017.
At one-factor analysis, 2-week regimens showed a trend toward a significantly higher efficacy than the 1-week regimens according to ITT criteria (OR: 1.44 with 95% CI of 1.10-2.84, P = 0.018), and were significantly effective at PP analysis (OR: 1.79 with 95% CI of 1.06%-3.03%, P = 0.029).
The PR group showed a trend of decreased frequency of CD4 + PD-1 + and CD8 + PD-1 + T cell subsets ( Figure 2(a) ) ( p =0.019, p =0.003).
Participants with MOH showed a trend toward higher PSQI global scores compared to those without MOH, which reached statistical significance only at Week 12 ( p = 0.019).
In Model 3 (adjusted for age, sex, and mGS), late log[CCL2] remained associated with change in ventricular volume and late log[IL-6] showed a trend (CCL2, β =33.41, 95% CI 7.22–59.60, p = 0.019; IL-6, β = 14.16, 95% CI −0.02–28.34, p = 0.050).
Low expression levels of SYNE1, SULT1A1, and FAM76A were significantly associated with poor OS (HR = 0.6, 0.61, and 0.58, respectively; P < 0.002), while COL10A1 showed a trend toward good prognosis (HR = 1.25; P = 0.019) (Fig. 3 A).
A McNemar test with a Bonferroni correction for multiple tests showed a trend toward the reduction of the proportion of patients with FSS score ≥4.5 after 1 ( p = 0.019) and 2 years ( p = 0.021) in comparison to baseline value.
Anxiety showed a trend towards improvement (SMD = −0.47; 95% CI −0.87 to −0.08; p –value = 0.019; 95% PI −1.60 to 0.66).
Achievement of CMR pre-HSCT showed a trend towards improved 2-year EFS (p=0.0198) but did not significantly change 2-year OS (p = 1).
Post hoc analysis demonstrated that favipiravir-treated patients showed a trend toward clinical improvement at day 7 among those with moderate COVID-19 (71.43% vs 55.86%, 95% CI: 0.0271 to 0.2843, P = 0.0199) and earlier resolution of fever and cough (p < 0.0001).
In tumors not amplified for CCND1 , higher baseline CCND1 expression was associated with a greater chance of CCCA although this only showed a trend to significance for letrozole+palbociclib ( P = 0.02; overall population P = 0.07).
Yet smaller studies recruited within population isolates showed a trend for the rare allele to be associated with low lung function (random-effect P = 0.02, N = 1623, Figure 5 ), and in contrast to the association with AAT serum levels, adjusting for PI S and Z alleles did not modify the association of rs4905179 with lung function ( Figure 6 ).
While task-irrelevant thermal input tended to prolong RTs in the visual task under low load ( p = 0.033, q = 0.099), task-irrelevant visual input showed a trend-level improvement in thermal-task accuracy under high load (3-back; p = 0.020, q = 0.060), consistent with a potential cross-modal effect.